Healthcare StocksKelun-Biotech Advances 30+ Oncology Candidates as ADC Pipeline Race Accelerates Through 2027Salvado•Mar 26, 2026
Corporate Earnings RiskFIRDAPSE Patent Expires February 2035, Threatens 70-80% Revenue Decline for Catalyst PharmaceuticalsViaNews Editorial Team (Markets)•Mar 12, 2026
